Funded Projects › H2020
CoCA · Comorbid Conditions of Attention deficit / hyperactivity disorder
Understanding mechanisms underlying comorbid disorders poses a challenge for developing precision medicine tools. Psychiatric disorders are highly comorbid, and are among the last areas of medicine, where classification is driven by phenomenology rather than pathophysiology. We will study comorbidity between the most frequent psychiatric conditions, ADHD, mood/anxiety, and substance use disorders, and a highly prevalent somatic disease, obesity. ADHD, a childhood-onset disorder, forms the entry into a lifelong negative trajectory characterized by these comorbidities. Common mechanisms underlying this course are unknown, despite their relevance for early detection, prevention, and treatment. Our interdisciplinary team of experts will integrate epidemiologic/genetic approaches with experimental designs to address those issues. We will determine disease burden of comorbidity, calculate its socioeconomic impact, and reveal risk factors. We will study biological pathways of comorbidity and derive biomarkers, prioritizing two candidate mechanisms (circadian rhythm and dopaminergic neurotransmission), but also leveraging large existing data sets to identify new ones. A pilot clinical trial to study non-pharmacologic, dopamine-based and chronobiological treatments will be performed, employing innovative mHealth to monitor and support patients’ daily life. Integration of findings will lead to prediction algorithms enhancing early diagnosis and prevention of comorbidity. Finally, we will screen to repurpose existing pharmacological compounds. Integrating complementary approaches based on large-scale, existing data and innovative data collection, we maximize value for money in this project, leading to insight into the mechanisms underlying this comorbidity triad with its huge burden for healthcare, economy, and society. This will facilitate early detection and non-invasive, scalable, and low-cost treatment, creating opportunities for substantial and immediate societal impact.
Consortium · 18 organisations
JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN
DE · €996,898
AARHUS UNIVERSITET
DK · €261,805
TARTU ULIKOOL
EE · €147,000
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
US · €312,000
STICHTING RADBOUD UNIVERSITEIT
NL
UNIVERSIDAD DE GRANADA
ES · €105,000
ACADEMISCH ZIEKENHUIS GRONINGEN
NL · €262,000
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
NL · €585,000
KARLSRUHER INSTITUT FUER TECHNOLOGIE
DE · €466,913
UNIVERSITAT DE BARCELONA
ES · €252,391
UNIVERSITATSMEDIZIN ROSTOCK
DE · €240,000
UNIVERSITATSKLINIKUM HEIDELBERG
DE · €339,658
KAROLINSKA INSTITUTET
SE · €202,000
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
ES · €326,996
CONCENTRIS RESEARCH MANAGEMENT GMBH
DE · €360,000
UNIVERSITETET I BERGEN
NO · €402,360
HGC HEALTHCARE CONSULTANTS GMBH
DE · €150,000
KING'S COLLEGE LONDON
UK · €589,000
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.